These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Author: Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Journal: Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078.
    Abstract:
    BACKGROUND: Lesion-to-brain contrast after gadolinium administration is significantly higher at 3.0 Tesla (T) compared to 1.5 T. The high in vivo relaxivity of gadobenate dimeglumine (Gd-BOPTA) may permit the use of lower-dose contrast agents. PURPOSE: To investigate whether low-dose contrast-enhanced MRI at 3.0 T using a high-relaxivity contrast agent (Gd-BOPTA) can achieve a comparable or improved contrast-to-noise ratio (CNR) for the detection of brain metastases compared with examination of the same patient at 1.5 T using a standard dose of gadopentetate dimeglumine (Gd-DTPA). MATERIAL AND METHODS: A total of 18 patients with known brain metastases were first imaged at 1.5 T with 0.1 mmol/kg Gd-DTPA. Patients returned at least 24 hours later for imaging at 3.0 T with Gd-BOPTA at cumulative doses of 0.025 mmol/kg, 0.05 mmol/kg, 0.075 mmol/kg, and 0.1 mmol/kg (0.1 mmol/kg body weight overall). The CNR of enhancing brain lesions compared to the normal contralateral white matter was calculated. For the 3.0 T study using different cumulative doses of Gd-BOPTA, the CNR of lesions was compared with CNR of the same lesions imaged at 1.5 T using 0.1 mmol/kg Gd-DTPA, by using the Wilcoxon matched-pairs signed-rank test. RESULTS: At 1.5 T with 0.1 mmol/kg Gd-DTPA, the mean CNR between enhanced lesions and cerebral white matter was 12.01 +/- 2.53. With 3.0 T imaging using different cumulative doses of Gd-BOPTA, the mean CNRs were 7.19 +/- 4.06, 15.31 +/- 6.37, 25.44 +/- 11.02, and 31.88 +/- 13.21. At 3.0 T with 0.05 mmol/kg Gd-BOPTA, CNR was 1.34-fold higher compared to CNR at 1.5 T with 0.1 mmol/kg Gd-DTPA (P <0.01). CONCLUSION: Comparable contrast enhancement of brain metastases can be achieved with a 0.05-mmol/kg dose of Gd-BOPTA at 3.0 T compared to imaging at 1.5 T using 0.1 mmol/kg Gd-DTPA.
    [Abstract] [Full Text] [Related] [New Search]